✦ LIBER ✦

Inhibition of stent occlusion by ampicillin-sulbactam in an in-vitro model

Book ID: 122484392
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 175 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)24306-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro activity of ampicillin/sulbacta

In vitro activity of ampicillin/sulbactam against enterococci determined by the time-kill method

✍ D'Amato, Richard F.; Mathew, Anna; Hochstein, Lisa; Cleri, Dennis J.; Johnson, J 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Comparative in vitro studies on the β-la

Comparative in vitro studies on the β-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae

✍ H. Grimm 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Efficacy of sulbactam in an in vitro mod

Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections

✍ W. R. Heizmann; F. Heilmann; Birgit Egeler; H. Werner 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 856 KB

Influence of Stent Edge Angle on Endothe

Influence of Stent Edge Angle on Endothelialization in An In Vitro Model

✍ Hamuro, Masao; Palmaz, Julio C.; Sprague, Eugene A.; Fuss, Cristina; Luo, Jian 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Review of an in vitro microfluidic model

Review of an in vitro microfluidic model of sickle cell vaso-occlusion

✍ J.M. Higgins; D.T. Eddington; S.N. Bhatia; L. Mahadevan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 195 KB

Simultaneous determination of ampicillin

Simultaneous determination of ampicillin, cefoperazone, and sulbactam in pharmaceutical formulations by HPLC with β-cyclodextrin stationary phase

✍ Tai-Li Tsou; Yu-Chuan Huang; Chiu-Wey Lee; An-Rong Lee; Hsian-Jenn Wang; Su-Hwei 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

## Abstract An accurate and reproducible method for the simultaneous determination of ampicillin (AMP), sulbactam (SUL), and cefoperazone (CFP) in pharmaceutical formulations by using HPLC with β‐CD stationary phase was developed. It involved the use of the added tetraethylammonium acetate (TEAA) r